Zenotech Laboratories MD, chairman, board of directors and AGM
BSE: 532039Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹39.50.
- Next results date: the board meets on 28 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹246 Cr2,190th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 2.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 28 Jul 2026
- −3.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,902
Zenotech Laboratories board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Company Secretary and Compliance OfficerAbdul Gafoor Mohammad
6 directors3 independent3 non-executive
- AZADAR HUSAIN ASGHAR MEHDI KHANNon-executive · joined Aug 2015 · 1 listed board
- JIGNESH ANANTRAY GORADIANon-executive · joined Jul 2015 · 1 listed board · 2 committee seats, 1 as chair
- JAGRUTI PRASHANT SHETHIndependent · joined Feb 2020 · reappointed Feb 2025 · 80 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
- RAKESHCHANDRA JAGDISHPRASAD SINHANon-executive · joined Feb 2020 · 1 listed board
- PREMAL HEMANT GANDHIIndependent · joined Jan 2025 · 20 months as independent · 1 listed board · 1 as independent · 2 committee seats
- NIKKHIL VENILAL KOTHHARIIndependent · joined Jan 2026 · 8 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- CHINTAN JITENDRA SHAH, left 26 Jan 2026: Tenure Completion
- KAVITA RAKESH SHAH, left 31 Mar 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 24 Sep 20266 of 6 present3 independent · 57 days in between
- 28 Jul 20266 of 6 present3 independent · 89 days in between
- 29 Apr 20266 of 6 present3 independent
Audit Committee
Chair JAGRUTI PRASHANT SHETH
JIGNESH ANANTRAY GORADIA, PREMAL HEMANT GANDHI
- 28 Jul 20263 of 3 present2 independent · 89 days in between
- 29 Apr 20263 of 3 present2 independent
Nomination and remuneration committee
Chair PREMAL HEMANT GANDHI
JIGNESH ANANTRAY GORADIA, JAGRUTI PRASHANT SHETH
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair JIGNESH ANANTRAY GORADIA
PREMAL HEMANT GANDHI, JAGRUTI PRASHANT SHETH
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair AZADAR HUSAIN ASGHAR MEHDI KHAN
JAGRUTI PRASHANT SHETH, JIGNESH ANANTRAY GORADIA
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- G S K A & Co.Peer-review certificate valid to Oct 2027
1 earlier auditor
- PKF Sridhar & Santhanam LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Zenotech Laboratories AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Zenotech Laboratories share news and announcements
Annual general meeting, 25 Sep 2026
10,205 shareholders on the register on 25 Sep 2026; present: 1 promoter and 60 others; votes counted by Mr. Mahadev Tirunagari / Mahadev Tirunagari.The company's voting result (opens in a new tab)
- Adoption of Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026 and the reports of Board of Directors and Auditors thereon.Ordinary99.95% for0.05% against
Against: promoters 0.00% · institutions 0.00% · other public 7.80%
Turnout: all 69.31% · promoters 100.00% · institutions 0.00% · other public 1.50%
- Approval for the appointment of Mr. Jignesh Anantray Goradia (DIN: 07229899), who retires by rotation and being eligible, has offered himself for re-appointment.Ordinary99.85% for0.15% against
Against: promoters 0.00% · institutions 0.00% · other public 21.82%
Turnout: all 69.31% · promoters 100.00% · institutions 0.00% · other public 1.50%
- Approval for Material Related Party Transaction(s) with Sun Pharmaceutical Industries Limited.OrdinaryPromoters have an interest in it78.17% for21.83% against
Against: promoters 0.00% · institutions 0.00% · other public 21.83%
Turnout: all 0.47% · promoters 0.00% · institutions 0.00% · other public 1.50%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Tax disputes
Reported in the filing for the quarter to Sep 2026.
- Tax disputeDeputy Commissioner of Income TaxSince 16 Feb 2022On-goingAt the filing before: No change
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- No
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.